Decibel Therapeutics, Inc.
DBTXDelisted Sep 25, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001656536
Decibel Therapeutics, Inc. was delisted on Sep 25, 2023; its insiders filed their last Form 4 on Sep 25, 2023; 37 institutions reported holding it in 13F filings for Q2 2023, worth $59.2M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Decibel Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 38 | 37 | −1 |
| Shares | 15.5M | 15.4M | −70.2K (−0.5%) |
| Value | $46.7M | $59.2M | +$12.6M (+26.9%) |
New holders (3)
Institutions that held Decibel Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acuitas Investments, LLC | 41,960 | $161.5K | 0.09% |
| Bailard, Inc. | 10,600 | $40.8K | 0.00% |
| Lazard Asset Management LLC | 3,970 | $15.0K | 0.00% |
Sold out (4)
Institutions that held Decibel Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Marquette Asset Management, LLC | 19,783 | $59.7K |
| Bank of America Corp | 750 | $2.27K |
| Simplex Trading, LLC | 204 | $0 |
| Financial Connections Group, Inc. | 300 | $0 |